Overview

Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
A Phase 1 study to evaluate the pharmacokinetics of ITCA 650 in subjects with mild and moderate renal impairment compared to the pharmacokinetics of subjects with normal renal function
Phase:
Phase 1
Details
Lead Sponsor:
Intarcia Therapeutics
Treatments:
Exenatide